Neurocrine Biosciences (NBIX) Misses Q4 EPS by 2c
Tweet
Share
E-mailGet Alerts NBIX Hot Sheet
Price: $155.64 -1.71%
EPS Growth %: -12.4%
Financial Fact:
General and administrative: 17.49M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: -12.4%
Financial Fact:
General and administrative: 17.49M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Neurocrine Biosciences (NASDAQ: NBIX) reported Q4 EPS of ($0.26), $0.02 worse than the analyst estimate of ($0.24).
For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- Dell’s earning report was bullish for Intel CPU demand, analyst says
- Geberit AG (GEBN:SW) (GBERY) PT Raised to CHF712 at Jefferies
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
